Phase 3 Clinical Trials With Primary Completion Dates in June 2023

This is a list of Phase 3 trials with primary completion dates in June 2023 for companies with a market cap less than $1B. For complete clinical trial coverage, please see our Trial Tracker tool. It includes information on all clinical trials for publicly traded companies, screenable by stock symbol, market cap, disease, completion date, and phase.

The primary completion date is the date that the final subject was examined or received an intervention for the purposes of final collection of data for the primary outcome. It provides advance notice that a company will be announcing trial results in the near future.

SymbolCompanyPrimary Completion DatePhaseNCT IDTitle
ALVOAlvotech2023-06-01Phase 3NCT05155293Clinical Study to Compare Efficacy and Safety of AVT06 and EU-Eylea (ALVOEYE)
ANVSAnnovis Bio, Inc.2023-06-01Phase 3NCT05357989A Double-blind Study to Investigate Efficacy and Safety of Buntanetap Compared With Placebo in Participants With Early PD
AXSMAxsome Therapeutics, Inc.2023-06-01Phase 3NCT05059223A Study to Assess the Efficacy and Safety of AXS-12 (Reboxetine) in Patients With Narcolepsy
AXSMAxsome Therapeutics, Inc.2023-06-01Phase 3NCT04947553Open-Label Safety Study of AXS-05 in Subjects With Alzheimer's Disease Agitation
CINGCingulate Inc.2023-06-01Phase 3NCT05631626Phase 3 Efficacy and Safety Study in Adults With ADHD Using CTx-1301.
CLVSQClovis Oncology, Inc.2023-06-01Phase 3NCT04227522Rucaparib MAintenance After Bevacizumab Maintenance Following Carboplatin Based First Line Chemotherapy in Ovarian Cancer Patients
CORTCorcept Therapeutics Incorporated2023-06-01Phase 3NCT04308590Efficacy and Safety of Relacorilant in Patients With Cortisol-Secreting Adrenal Adenomas
DBVTDBV Technologies S.A.2023-06-01Phase 3NCT03859700Follow-up of the EPITOPE Study to Evaluate Long-term Efficacy and Safety of DBV712 in Young Children
EBSEmergent BioSolutions Inc.2023-06-01Phase 3NCT05349617Safety and Immunogenicity of CHIKV VLP Vaccine PXVX0317 in Adults ≥65 Years
MMSIMerit Medical Systems, Inc.2023-06-01Phase 3NCT03960008Stereotactic Body Radiation Therapy (SBRT) vs Trans-Arterial Chemoembolization (TACE) as Bridge to Transplant
ORGOOrganogenesis Holdings Inc.2023-06-01Phase 3NCT04636229Efficacy of Amniotic Suspension Allograft in Patients With Osteoarthritis of the Knee
SAGESage Therapeutics, Inc.2023-06-01Phase 3NCT03864614A Study to Evaluate SAGE-217 in Adult Participants With Major Depressive Disorder (MDD)
SLNOSoleno Therapeutics, Inc.2023-06-01Phase 3NCT03714373Open-Label Extension Study of DCCR in PWS Followed by Double-Blind, Placebo-Controlled, Randomized Withdrawal Period
TNXPTonix Pharmaceuticals Holding Corp.2023-06-01Phase 3NCT05273749A Phase 3 Study to Evaluate the Efficacy and Safety of TNX-102 SL Taken Daily in Patients With Fibromyalgia
ZLDPFZealand Pharma A/S2023-06-01Phase 3NCT05378672A Research Study to Investigate the Safety and Effect of Dasiglucagon as a Hypoglycemia Rescue Therapy and How it Works in the Body of Children Under 6 Years of Age With Type 1 Diabetes